Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(34:2) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 124 | pmol/sample |
| - | PE(34:2) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 202 | pmol/sample |
| - | PE(34:2) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 176 | pmol/sample |
| - | PE(34:2) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 78.9 | pmol/sample |
| - | PE(34:2) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 80.1 | pmol/sample |
| - | PE(34:2) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 82.4 | pmol/sample |
| - | PE(34:2) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 167 | pmol/sample |
| - | PE(34:2) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 166 | pmol/sample |
| - | PE(34:2) | C | 0.0 | BCD100322A01 | 123 | pmol/sample |
| - | PE(34:2) | C | 0.5 | BCD100322A03 | 177 | pmol/sample |
| - | PE(34:2) | C | 1.0 | BCD100322A07 | 196 | pmol/sample |
| - | PE(34:2) | C | 2.0 | BCD100322A11 | 197 | pmol/sample |
| - | PE(34:2) | C | 4.0 | BCD100322A15 | 65.8 | pmol/sample |
| - | PE(34:2) | C | 8.0 | BCD100322A19 | 69.5 | pmol/sample |
| - | PE(34:2) | C | 12.0 | BCD100322A23 | 85.7 | pmol/sample |
| - | PE(34:2) | C | 24.0 | BCD100322A27 | 168 | pmol/sample |
| - | PE(34:2) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 215 | pmol/sample |
| - | PE(34:2) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 212 | pmol/sample |
| - | PE(34:2) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 177 | pmol/sample |
| - | PE(34:2) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 77.9 | pmol/sample |
| - | PE(34:2) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 81.2 | pmol/sample |
| - | PE(34:2) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 165 | pmol/sample |
| - | PE(34:2) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 245 | pmol/sample |
| - | PE(34:2) | 25OH-Chol | 0.5 | BCD100322A04 | 157 | pmol/sample |
| - | PE(34:2) | 25OH-Chol | 1.0 | BCD100322A08 | 216 | pmol/sample |
| - | PE(34:2) | 25OH-Chol | 2.0 | BCD100322A12 | 114 | pmol/sample |
| - | PE(34:2) | 25OH-Chol | 4.0 | BCD100322A16 | 81.6 | pmol/sample |
| - | PE(34:2) | 25OH-Chol | 8.0 | BCD100322A20 | 74.7 | pmol/sample |
| - | PE(34:2) | 25OH-Chol | 12.0 | BCD100322A24 | 71.8 | pmol/sample |
| - | PE(34:2) | 25OH-Chol | 24.0 | BCD100322A28 | 203 | pmol/sample |